Valuation: Kintor Pharmaceutical Limited

Market Cap 835M 978M 125M 109M 102M 93.43M 175M 11.92B 175M 1.23B 474M 6.09B 468M 458M 19.62B P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 889M 1.04B 133M 116M 109M 99.46M 187M 12.68B 187M 1.31B 505M 6.48B 498M 487M 20.88B EV / Sales 2024
75,794,130x
EV / Sales 2025 28,245,180x
Free-Float
88.01%
Yield 2024 *
-
Yield 2025 -
1 day+4.21%
1 week+3.12%
Current month+15.79%
1 month+9.70%
3 months-12.00%
6 months-34.00%
Current year+1.02%
1 week 1.8
Extreme 1.8
2.05
1 month 1.6
Extreme 1.6
2.05
Current year 1.6
Extreme 1.6
4.7
1 year 1.6
Extreme 1.6
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
72.7
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 24/03/2009
Director of Finance/CFO 48 21/09/2026
Chief Tech/Sci/R&D Officer 49 01/09/2020
Director TitleAgeSince
Director/Board Member 62 12/08/2019
Director/Board Member 61 12/08/2019
Chairman 64 24/03/2009
Date Insider Type Main position Quantity % Market Cap. Importance
17/7/26 Other

Chief Executive Officer

145,000 0.0291%
21/5/26 Other

Chief Executive Officer

38,000 0.0076%
18/5/26 Other

Chief Executive Officer

170,000 0.0341%
Change 5-day change 1-year change 3-year change Capi.($)
+4.21%+3.12%-26.12%-28.52% 120M
-0.07%+5.66%+54.34%+113.69% 74.33B
-1.45%-1.43%+36.82%+80.62% 62.26B
-0.66%+7.14%+39.36%+29.20% 27.72B
-0.15%+0.75%-16.69%+361.67% 26.42B
+2.93%+4.32%+2.18%-3.60% 24.62B
+0.84%+7.70%+26.09%-10.70% 20.72B
+0.87%-2.52%+151.81%+328.17% 15.01B
+1.63%+2.20%+46.92%+170.72% 14.18B
+1.30%-1.61%-10.37%+815.51% 13.48B
Average +0.99%+0.56%+30.43%+185.68% 27.89B
Weighted average by Cap. +0.13%+2.10%+37.21%+150.12%

Financials

2024 2025
Net sales 5 5.85 0.75 0.65 0.61 0.56 1.05 71.34 1.05 7.36 2.84 36.43 2.8 2.74 117.45 32.68 38.26 4.88 4.26 4.01 3.66 6.86 466.31 6.86 48.08 18.55 238.13 18.32 17.92 767.69
Net income -155M -182M -23.18M -20.25M -19.04M -17.37M -32.6M -2.22B -32.61M -228M -88.16M -1.13B -87.04M -85.13M -3.65B -200M -234M -29.87M -26.1M -24.53M -22.39M -42.01M -2.86B -42.02M -294M -114M -1.46B -112M -110M -4.7B
Net Debt -15.68M -18.36M -2.34M -2.05M -1.92M -1.75M -3.29M -224M -3.29M -23.07M -8.9M -114M -8.79M -8.6M -368M 53.86M 63.05M 8.04M 7.03M 6.6M 6.03M 11.31M 768M 11.31M 79.24M 30.58M 392M 30.19M 29.53M 1.27B
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
122
Date Price Change Volume
22/09/26 HKD 1.980 +4.21% 1,105,500
21/09/26 HKD 1.900 +4.40% 524,000
18/09/26 HKD 1.820 -3.70% 864,000
17/09/26 HKD 1.890 +0.53% 771,500
16/09/26 HKD 1.880 0.00% 232,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9939 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!